+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cystinosis Drug"

Cystinosis - Pipeline Insight, 2024 - Product Thumbnail Image

Cystinosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nephropathic Cystinosis - Pipeline Insight, 2024 - Product Thumbnail Image

Nephropathic Cystinosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Nephropathic Cystinosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nephropathic Cystinosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cystinosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cystinosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The Cystinosis Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. Cystinosis is a rare, genetic disorder that affects the kidneys, eyes, muscles, and other organs. Treatment for cystinosis includes cysteamine, a drug that helps reduce the amount of cystine in the body. Cysteamine is available in both oral and intravenous forms. Other drugs used to treat cystinosis include cysteamine eye drops, cysteamine cream, and cysteamine tablets. The Cystinosis Drug market is a small but growing market, with a number of companies offering treatments for cystinosis. These companies include Raptor Pharmaceuticals, Horizon Therapeutics, and Retrophin. Additionally, several research organizations are actively researching new treatments for cystinosis, including the Cystinosis Research Foundation and the Cystinosis Clinical Research Network. Show Less Read more